Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genome Scan Exposes HIV Infection Proteins

By LabMedica International staff writers
Posted on 14 Oct 2008
Molecular virologists have used the latest siRNA technology to interrogate the human genome one gene at a time in order to identify the host cell factors used by the AIDS virus to enter cells and commandeer the cells' protein synthetic machinery.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) in collaboration with colleagues at the Burnham Institute for Medical Research (La Jolla, CA, USA) combined genome-wide siRNA analyses with interrogation of human interactome (cellular protein-protein interaction network) databases to assemble a host-pathogen biochemical map containing 213 confirmed host cellular factors and 11 HIV-1-encoded proteins. More...


Data published in the October 3, 2008, issue of the journal Cell revealed that after high throughput screening of more than 144,000 siRNAs it was possible to identify protein complexes that regulate ubiquitin conjugation, proteolysis, DNA-damage response, and RNA splicing as important modulators of early-stage HIV-1 infection.

Over 40 new factors were shown to specifically influence the initiation and/or kinetics of HIV-1 DNA synthesis, including cytoskeletal regulatory proteins, modulators of posttranslational modification, and nucleic acid-binding proteins. Another 15 proteins with diverse functional roles, including nuclear transport, prostaglandin synthesis, ubiquitination, and transcription, were found to influence nuclear import or viral DNA integration.

"HIV has just nine genes, coding for 15 proteins, compared to bacteria, which harbor several thousand genes, or humans, with over 20,000 genes,” said senior author Dr. Sumit K. Chanda, associate professor of infectious and inflammatory diseases at the Burnham Institute for Medical Research. "We have known for a long time that HIV hijacks our cellular proteins to complete its life cycle. This study now lays out its flight plan.”

This new understanding of the molecular relationship between host cell and the AIDS virus could lead to the development of a new class of HIV therapeutics aimed at disrupting the human-HIV interactions that lead to viral infection.

Related Links:

Salk Institute for Biological Studies
Burnham Institute for Medical Research


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.